Mandate

Vinge advises the majority shareholders Altor, Telia Company, Time For Growth and Zenith VC in the divestment of shares in Marshall Group

Vinge advises the majority shareholders Altor, Telia Company, Time For Growth and Zenith VC in connection with the divestment of shares in Marshall Group AB (publ) (”Marshall Group”) to HongShan Group, formerly known as Sequoia China. The Marshall Family will continue as owner in the Marshall Group.

Marshall Group is the audio, tech and design powerhouse uniting musicians and music lovers through genre-breaking innovation. Marshall, the flagship brand, is uniquely positioned with over 60 years of rock’n’roll attitude on stage, at home, and on the go, across more than 90 markets. Marshall Group has more than EUR 400 million in revenues and brings together around 800 talented people across eight locations globally.

The transaction is subject to applicable antitrust approvals.

Vinge’s team consisted of Christina Kokko, Johanna Wiberg, Elsie Nassar, Ellinor Wargenbrant and Emma Lundberg (M&A), David Andersson and Joel Magnusson (Capital Markets & Public M&A), Albert Wållgren, Karl-Gustaw Tobola and William Carlberg Johansson (Banking & Finance), Rebecka Målquist (Intellectual Property), Martin Boström and Mario Saad (Commercial Agreements), Carla Håkansson and Siri Blomberg (IT and GDPR), Emil Lindwall (Employment and Benefits), Hayaat Ibrahim and Gulestan Ali (Compliance), Hanna Kövamees (Real Property and Environment), Marcus Glader, Sebastian Örndahl, Lovisa Lewin and Alva Chambert (EU, Competition and Regulatory), Ellinore Boström Andersson, Cecilia Loctander, Emelie Schoning and Gabriella Balbo (Transaction Support Coordinators).

Read the press release.

Related

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of their production facility in Uppsala to Ofichem. The Uppsala site specializes in small-scale, early-phase development work.
August 13, 2025

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025